Amgen Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 24.20%

Amgen Inc. EBIT Margin is 24.20% for the Trailing 12 Months (TTM) ending March 31, 2025, a 5.51% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Amgen Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 22.93%, a -46.10% change year over year.
  • Amgen Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 42.55%, a 16.22% change year over year.
  • Amgen Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 36.61%, a -0.18% change year over year.
  • Amgen Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 36.68%, a -10.24% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin